Cognition and perception deficits in fibromyalgia and rheumatoid arthritis;Déficit mnésicos y perceptivos en la fibromialgia y la artritis reumatoide

Reumatologia Clinica

Volumn 3, Issue 3, 2007, Pages 101-109

  Roldán Tapia, Lola ^a   Cánovas López, Rosa ^a   Cimadevilla, José ^a   Valverde, Matías ^a  

^a UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

Cognitive reserve; Fibromyalgia; Memory; Neuropsycology; Neurpsycologic alterations; Rheumatoid arthritis

Indexed keywords

ADULT; ARTICLE; ATTENTION; CHRONIC PAIN; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; FIBROMYALGIA; HUMAN; MENTAL PERFORMANCE; PERCEPTION; PERCEPTION DISORDER; RHEUMATOID ARTHRITIS; SPATIAL MEMORY; SPATIAL ORIENTATION; VISION; VISUOMOTOR COORDINATION;

EID: 34548693702     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(07)73676-8     Document Type: Article

References (62)

1. Sociedad Española de Reumatología. Estudio EPISER: Prevalencia de las enfermedades reumáticas en la población española. Madrid: Merck, Sharp & Dohme; 2001.
2. Glass JM, Park DC, Minear M, Crofford LJ. Memory beliefs and function in fibromyalgia patients. J Psychosom Res. 2005;58:263-9.
3. Sephton SE, Studts JL, Hoover K, Weissbecker I, Lynch G, Ho I, et al. Biological and psychological factors associated with memory fuction in fibromyalgia syndrome. Health Psychol. 2003;6:592-7.
4. Dick B, Eccleston C, Crombez G. Attentional functioning in fibromyalgia, rheumatoid arthritis and musculoskeletal pain patients. Arthritis Rheum. 2002;47:639-44.
5. Bartolini M, Candela M, Brugni M, Catena L, Mari F, Pomponio G, et al. Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol. 2002;20:491-7.
6. Park DC, Glass JM, Minear M, Crofford LJ. Cognitive function in fibromyalgia patients. Arthritis Rheum. 2001;44:2125-33.
7. Shur J. Neuropsychological impairment in fibromyalgia. Relation to depression, fatigue and pain. J Psychosom Res. 2003;55:321-9.
8. Stern Y. The concept of cognitive reserve: A catalyst for research. J Clin Exp Neuropsychol. 2003;25:589-93.
9. Sanchez JL, Rodriguez M, Carro J. Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subject of spanish nationality. Neuropsy Neuropsychol Behav Neurol. 2002;15:113-22.
10. a ed. New York: Oxford University Press; 1995.
11. Golden CJ. Test de Colores y Palabras (Stroop). Madrid: TEA; 1994.
12. Wechsler D. Escala de Inteligencia de Wechsler para adultos. Madrid: TEA; 1993.
13. Rey A. Test de copia y reproducción de memoria de figuras geométricas complejas. Madrid: TEA; 1997.
14. Achiron A, Polliack M, Rao SM, Barak Y, Lavie M, Appelboin N, et al. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry. 2005;76:744-9.
15. Wechsler D. Escala de memoria de Wechsler-III (WMS-III). Madrid: TEA; 2004.
16. Benton AL, Sivan AB, Hamsher KD, Varney NR, Otfried S. Contribution to Neuropsychological assesment. 2.a ed. New York: Oxford University Press; 1994.
17. Grace GM, Nielson WR, Hopkins M, Berg MA. Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol. 1999;4:477-87.
18. Leavitt F, Katz RS. Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol. 2006;33:127-32.
19. Grisart J, Van der Linden M, Masquelier E. Controlled Processes and automaticity in memory functioning in fibromyalgia patients: Relation with emocional distress and hypervigilance. J Clin Exp Neuropsychol. 2002;8:994-1009.
20. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20 Suppl 2:S69-74.
21. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep. 2004;4:374-80.
22. Ciesielski AS, Samson S, Steinhoff BJ. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study. Epilepsy Behav. 2006;9:424-31.
23. Hindmarch I, Trick L, Ridout F. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology (Berl). 2005;183:133-43.
24. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol. 2004;3:618-21.
25. Montgomery SA. Pregabalin for the treatment of generalised anxiety disorder. Expert Opin Pharmacother. 2006;7:2139-54.
26. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-73.
27. Munizza C, Olivieri L, Di Loreto G, Dionisio P. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder. Curr Med Res Opin. 2006;22:1703-13.
28. Martinon-Torres G, Fioravanti M, Grimley EJ. Trazodone for agitation in dementia. Cochrane Database Syst Rev. 2004;18(4):CD004990.
29. Lennkh C, Fischer P, Kufferle B, Kasper S. Occurrence of trazodone-induced delirium. Int Clin Psychopharmacol. 1998;13:225-8.
30. Silverstone PH, Rue JE, Franklin M, Hallis K, Camplin G, Laver D, et al. The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers. Int Clin Psychopharmacol. 1994;9:173-8.
31. Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients. A review. Drugs Aging. 1994;5:192-9.
32. Amado-Boccara I, Gougoulis N, Poirier-Littre MF, Galinowski A, Loo H. Effects of antidepressants on cognitive functions. Review of the literature. Encephale. 1994;20:65-77.
33. Martinón-Torres G, Fioravanti M, Grimley Evans J. Trazodona para la agitación en la demencia (Revisión Cochrane traducida). De La Biblioteca Cochrane Plus, número 4, 2006. Oxford: Update Software Ltd.
34. Caballero J, Hitchcock M, Beversdorf D, Scharre D, Nahata M. Long-term effects of antidepressants on cognition in patients with Alzheimer's disease. J Clin Pharm Ther. 2006;31:593-8.
35. Simis S, Nitrini R. Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke. Arq Neuropsiquiatr. 2006;64:412-7.
36. Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, et al. Mood and neuropsychological changes in women with midlife depression treated with escitalopram. J Clin Psychopharmacol. 2006;26:361-6.
37. Rose EJ, Simonotto E, Spencer EP, Ebmeier KP. The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology (Berl). 2006;185:339-47.
38. Egashira N, Matsumoto Y, Mishima K, Iwasaki K, Fujioka M, Matsushita M, et al. Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. Pharmacol Biochem Behav. 2006;83:161-7.
39. Friedman JI, Ocampo R, Elbaz Z, Parrella M, White L, Bowler S, et al. The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia. J Clin Psychopharmacol. 2005;25:237-42.
40. Ng KF, Yuen TS, Ng VM. A comparison of postoperative cognitive function and pain relief with fentanyl or tramadol patient-controlled analgesia. J Clin Anesth. 2006;18:205-10.
41. Freye E, Levy JV. The effects of tramadol on pain relief, fast EEG-power spectrum and cognitive function in elderly patients with chronic osteoarthritis (OA). Acute Pain. 2006;8:55-61.42.
42. Katz WA. Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs. 1996;52 Suppl 3:39-47.
43. Puga F, Veiga H, Cagy M, McDowell K, Piedade R, Ribeiro P. Analysis of the influence of bromazepam on cognitive performance through the visual evoked potential (P300). Arq Neuropsiquiatr. 2005;63:228-34.
44. Schaffler K, Klausnitzer W. Placebo-controlled study on acute and subchronic effects of buspirone vs bromazepam utilizing psychomotor and cognitive assessments in healthy volunteers. Pharmacopsychiatry. 1989;22:26-33.
45. Fontaine R, Mercier P, Beaudry P, Annable L, Chouinard G. Bromazepam and lorazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations. Acta Psychiatr Scand. 1986;74:451-8.
46. Schuck S, Allain H, Gandon JM, Patat A, Millet V, Le Coz F. Effect of bromazepam versus placebo on inhibition and waiting capacity in young women with traits of anxiety. Fundam Clin Pharmacol. 1998;12:463-7.
47. Munte TF, Gehde E, Johannes S, Seewald M, Heinze HJ. Effects of alprazolam and bromazepam on visual search and verbal recognition memory in humans: a study with event-related brain potentials. Neuropsychobiology. 1996;34:49-56.
48. Bourin M, Auget JL, Colombel MC, Larousse C. Effects of single oral doses of bromazepam, buspirone and clobazam on performance tasks and memory. Neuropsychobiology. 1989;22:141-5.
49. Drabant S, Tomlo J, Toth M, Peterfai E, Klebovich I. The cognitive effect of alprazolam in healthy volunteers. Acta Pharm Hung. 2006;76:25-31.
50. Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, et al. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs. J Clin Psychopharmacol. 2006;26:519-23.
51. Pomara N, Facelle TM, Roth AE, Willoughby LM, Greenblatt DJ, Sidtis JJ. Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration. Psychopharmacology (Berl). 2006;185:487-94.
52. Tiplady B, Bowness E, Stien L, Drummond G. Selective effects of clonidine and temazepam on attention and memory. J Psychopharmacol. 2005;19:259-65.
53. Beracochea D. Anterograde and retrograde effects of benzodiazepines on memory. Sci World J. 2006;16:1460-5.
54. Takiguchi A, Masuoka T, Yamamoto Y, Mikami A, Kamei C. Potentiation of ethanol in spatial memory deficits induced by some benzodiazepines. J Pharmacol Sci. 2006;101:325-8.
55. Reder LM, Oates JM, Thornton ER, Quinlan JJ, Kaufer A, Sauer J. Drug-induced amnesia hurts recognition, but only for memories that can be unitized. Psychol Sci. 2006;17:562-7.
56. Nogueira AM, Pompeia S, Galduroz JC, Bueno OF. Effects of a benzodiazepine on free recall of semantically related words. Hum Psychopharmacol. 2006;21:327-36.
57. Fisher J, Hirshman E, Henthorn T, Arndt J, Passannante A. Midazolam amnesia and short-term/working memory processes. Conscious Cogn. 2006;15:54-63.
58. Maruff P, Werth J, Giordani B, Caveney AF, Feltner D, Snyder PJ. A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam. Psychopharmacology (Berl). 2006;186:7-17.
59. Veltmeyer MD, Clark CR, McFarlane AC, Felmingham KL, Bryant RA, Gordon E. Integrative assessment of brain and cognitive function in posttraumatic stress disorder. J Integr Neurosci. 2005;4:145-59.
60. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann N Y Acad Sci. 2004;1032:141-53.
61. Raphael KG, Janal MN, Nayak S. Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. Pain Med. 2004;5:33-41.
62. Roy-Byrne P, Smith WR, Goldberg J, Afari N, Buchwald D. Post-traumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med. 2004;34:363-8.